Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy

Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes ‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy ‘Like Christmas’: woman’s relief after test finds she can skip chemotherapy Millions of women with breast cancer could be spared.

Summary by Glance · The Guardian Australia